Showing results (41-50 of 85) with videos related to

Sort By:
Pageof 9
Cancer Treatment Reviews|July 31, 2024
Hormone receptor-positive early breast cancer in young women: A comprehensive reviewBenjamin Walbaum, Isabel García-Fructuoso, Olga Martínez-Sáez, et al.
Breast (Edinburgh, Scotland)|May 30, 2024
Prediction of response to neoadjuvant chemotherapy by MammaTyper® across breast cancer subtypes: A retrospective cross-sectional studyFrancesco Schettini, Silvana Saracchini, Anna Bassini, et al.
Molecular and Clinical Oncology|April 8, 2020
Palbociclib added to ongoing endocrine therapy for hormone receptor-positive HER2-negative metastatic breast cancer: A case report seriesFrancesco Schettini, Irene De Santo, Carmen G Rea, et al.
Breast Cancer Research : BCR|May 15, 2020
Frequency and spectrum of PIK3CA somatic mutations in breast cancerOlga Martínez-Sáez, Nuria Chic, Tomás Pascual, et al.
Medical Sciences (Basel, Switzerland)|November 24, 2025
Virtual Biomarkers and Simplified Metrics in the Modeling of Breast Cancer Neoadjuvant Therapy: A Proof-of-Concept Case Study Based on Diagnostic ImagingGraziella Marino, Maria Valeria De Bonis, Marisabel Mecca, et al.
Scientific Reports|July 24, 2023
Computational reactive-diffusive modeling for stratification and prognosis determination of patients with breast cancer receiving OlaparibFrancesco Schettini, Maria Valeria De Bonis, Carla Strina, et al.
Breast Cancer Research and Treatment|August 10, 2020
Immune system and angiogenesis-related potential surrogate biomarkers of response to everolimus-based treatment in hormone receptor-positive breast cancer: an exploratory studyFrancesco Schettini, Navid Sobhani, Anna Ianza, et al.
Oncotarget|February 1, 2018
Combined effect of obesity and diabetes on early breast cancer outcome: a prospective observational studyGiuseppe Buono, Anna Crispo, Mario Giuliano, et al.
The Lancet. Oncology|September 9, 2019
Endocrine treatment versus chemotherapy in postmenopausal women with hormone receptor-positive, HER2-negative, metastatic breast cancer: a systematic review and network meta-analysisMario Giuliano, Francesco Schettini, Carla Rognoni, et al.
Breast (Edinburgh, Scotland)|December 30, 2017
Human epidermal growth factor receptor 2 dual blockade with trastuzumab and pertuzumab in real life: Italian clinical practice versus the CLEOPATRA trial resultsSabino De Placido, Mario Giuliano, Francesco Schettini, et al.
Pageof 9